Phosphorylation of Grb10 by mitogen-activated protein kinase:: Identification of Ser150 and Ser476 of human Grb10ζ as major phosphorylation site

被引:12
作者
Langlais, P
Wang, CH
Dong, LQ
Carroll, CA
Weintraub, ST
Liu, F
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78229 USA
[3] Wuhan Univ, Coll Med, Dept Physiol, Wuhan 430071, Peoples R China
[4] Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA
关键词
D O I
10.1021/bi050413i
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Grb10 is a Src-homology 2 (SH2) and Pleckstrin-homology (PH) domain-containing protein that binds to several autophosphorylated receptor tyrosine kinases including the insulin receptor (IR). Our previous studies showed that Grb10 underwent insulin-stimulated serine phosphorylation, yet the kinase(s) responsible for phosphorylation and the sites of the phosphorylation remain unknown. In this report, we show that Grb10 is a direct substrate of the p42/44 mitogen-activated protein kinase (MAPK). In addition, we found that inhibition of the MAPK signaling pathway reduced Grb10 phosphorylation in cells. Using site-directed mutagenesis, phosphopeptide mapping, and capillary HPLC -electrospray-tandem mass spectrometry analysis, we identified Ser(150), Ser(418), and Ser(476) of human Grb10 zeta as MAPK-mediated in vitro phosphorylation sites. In vivo labeling and two-dimensional phosphopeptide mapping studies revealed that Ser(150) and Ser(476) of human Grb10 zeta are phosphorylated in intact cells. Replacing Ser(150) and Ser476 with alanines reduced the inhibitory effect of human Grb10 zeta on insulin-stimulated IRS1 tyrosine phosphorylation. Taken together, our findings suggest that phosphorylation of the adaptor protein may provide a feedback inhibitory mechanism by which Grb10 regulates insulin signaling.
引用
收藏
页码:8890 / 8897
页数:8
相关论文
共 32 条
[1]   The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Cζ [J].
Cariou, B ;
Perdereau, D ;
Cailliau, K ;
Browaeys-Poly, E ;
Béréziat, V ;
Vasseur-Cognet, M ;
Girard, J ;
Burnol, AF .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) :6959-6970
[2]   Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism [J].
Charalambous, M ;
Smith, FM ;
Bennett, WR ;
Crew, TE ;
Mackenzie, F ;
Ward, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8292-8297
[3]  
DAVIS RJ, 1993, J BIOL CHEM, V268, P14553
[4]   Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action [J].
Deng, YP ;
Bhattacharya, S ;
Swamy, OR ;
Tandon, RC ;
Wang, Y ;
Janda, R ;
Riedel, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (41) :39311-39322
[5]   Cloning, chromosome localization, expression, and characterization of an Src homology 2 and pleckstrin homology domain-containing insulin receptor binding protein hGrb10 gamma [J].
Dong, LQ ;
Du, HY ;
Porter, SG ;
Kolakowski, LF ;
Lee, AV ;
Mandarino, J ;
Fan, JB ;
Yee, D ;
Liu, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29104-29112
[6]   Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase [J].
Ferrell, JE ;
Bhatt, RR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (30) :19008-19016
[7]   Ultrasensitivity in the mitogen-activated protein kinase cascade [J].
Huang, CYF ;
Ferrell, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) :10078-10083
[8]  
KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367
[9]   Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family [J].
Langlais, P ;
Dong, LQ ;
Hu, DR ;
Liu, F .
ONCOGENE, 2000, 19 (25) :2895-2903
[10]   Negative regulation of insulin-stimulated mitogen-activated protein kinase signaling by Grb10 [J].
Langlais, P ;
Dong, LLQ ;
Ramos, FJ ;
Hu, DR ;
Li, YH ;
Quon, MJ ;
Liu, F .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (02) :350-358